GlassScriptPhysician profile
Scott Jeffrey Dunitz
NPI 1316914542
$185,743.34
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,069 · 2020: $1,443 · 2021: $223 · 2022: $450 · 2023: $180K · 2024: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $180K · Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $180,400.00 |
| Food and Beverage | $159.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $184,429.05 | 2019-2023 | |
| Omnilife Science, INC | $404.80 | 2021-2022 | |
| Encore Medical, LP | $159.45 | 2019 | |
| Stryker Corporation | $136.40 | 2019-2024 | Blueprint Patient Specific Instrumentation |
| Pacira Therapeutics, INC. | $129.69 | 2019-2021 | |
| Total Joint Orthopedics, INC. | $97.83 | 2020 | |
| Baudax Bio INC. | $79.57 | 2020 | |
| Bioventus LLC | $46.51 | 2022-2024 | Durolane, Durolane |
| Pacira Pharmaceuticals Incorporated | $43.55 | 2022 | |
| Zimmer Biomet Holdings, INC. | $35.48 | 2020 | |
| Davol INC. | $30.28 | 2024 | Arista Ah Flexitip |
| Orthalign INC | $28.92 | 2021 | |
| Sanofi-Aventis U.S. LLC | $24.62 | 2019 | |
| Smith+Nephew, INC. | $18.78 | 2021 | |
| Horizon Therapeutics Plc | $18.75 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap Biologics, LLC | $16.80 | 2021 | |
| Depuy Synthes Sales INC. | $16.03 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.72 | 2023 | Seglentis |
| Zyla Life Sciences, INC. | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Dunitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.